+€5B
Annual revenue
A mid-sized pharmaceutical company faced declining operational performance at four key European sites producing oral solid blister packs. EFESO partnered to implement a structured Operational Excellence program, harmonizing processes, improving efficiency, and embedding a culture of continuous improvement.
Industry: Life Sciences
Service: Factory Planning
Service: Manufacturing
Service: Operational Excellence
A mid-sized pharmaceutical company present in more than 140 countries, with annual revenues exceeding €5 billion. The company operates across multiple therapeutic areas and manages a global production network with plants organized into three divisions: Pharma, Chemicals (API production), and Diagnostics. The focus of this program was on oral solid blister pack production at four strategic European sites.
+€5B
Annual revenue
+140
Countries with presence
“…We were impressed by how quickly EFESO’s consultants understood the specifics of our business, and by their ability to engage our staff…
“
Rapid growth and multiple acquisitions led to the coexistence of different production systems that were never harmonized. By Q4 2022, the company faced:
These factors highlighted the need for a structured intervention to improve efficiency, quality, and delivery punctuality.
EFESO’s Operational Excellence and Digital Transformation programs delivered measurable operational improvements, cost savings, and cultural change across the organization.
90%
Average OTIF achieved in under two years
969M
Blisters produced (+10% vs 2022)
5–8%
Reduction in unit conversion costs, delivering €10–12M savings
EFESO deployed a multi-phase Operational Excellence program:
The program integrated Lean Manufacturing, Change Management, and Performance Management, emphasizing rapid implementation, milestone celebration, and leadership engagement.